The investigation used a micro-Multiphysics Agent-based model, or micro-MPA, developed to connect the mechanics of bone tissue with the cellular and molecular events that shape regeneration. The framework combines three domains: micro-finite element analysis for local mechanical strain energy density, micro-finite difference calculations for cytokine reaction, diffusion and decay, and discrete agents representing cells that migrate, divide, differentiate and die. Osteocytes act as the principal mechanical sensors, changing production of sclerostin, receptor activator of nuclear factor kappa-B ligand and osteoprotegerin according to their mechanical environment. Low mechanical strain promotes signals associated with osteoclast recruitment, whereas sufficiently strong stimulation can suppress sclerostin and permit osteoblast-mediated bone formation.

The model was based on longitudinal micro-computed tomography data from female PolgA mice with a mitochondrial mutation that produces premature ageing. A 0.5-millimetre osteotomy was stabilised with an external fixator. After the protocol-defined bridging point at approximately three weeks after surgery, animals received either habitual loading through the fixator or an individualised cyclic loading regimen at 10 hertz for 3,000 cycles three times per week. Weekly scans at a 10.5-micrometre isotropic resolution tracked mineralised tissue across the defect. The young cohort underwent surgery at 12 weeks and was evaluated at 19 weeks, while the aged cohort underwent surgery at 35 weeks and was evaluated at 42 weeks.

Mechanical boundary conditions were first calibrated in young animals through a hierarchical grid search designed to reproduce bone-volume fraction in both habitual and cyclic loading conditions. Habitual loading matched held-out young control animals with a 3.8% root mean square error. Calibrating cyclic loading against the young loading group produced a 4.5% error and reproduced the prominent increase in lateral bone formation, while remaining close to the experimental medial response. In the calibrated mechanical environment, the fixator did more than stabilise the fracture: it shared part of the applied force with the healing tissue and introduced bending that shielded the lateral cortex during habitual loading. Additional cyclic loading partly offset this asymmetry by generating high strain in the lateral callus.

Once these conditions were fixed, the researchers tested two biological scenarios in the aged animals. In the first, native cortical osteocytes and osteocytes newly embedded in the callus both received a degenerated phenotype. In the second, the native cortex retained its aged parameters, but the callus osteocytes received the youthful baseline. The degenerated state doubled both the assumed sclerostin production rate and the strain-energy-density threshold required for mechanosensitivity. These were parameter assumptions adapted from descriptions of age-related impairment, not values directly measured in the mice. Osteocyte density and embedding rate were also held constant across conditions, so the comparison isolated selected aspects of cellular function rather than differences in cell number.

The distinction between the two scenarios was pronounced under cyclic loading. With degenerated callus osteocytes, the simulation produced widespread resorption and little formation despite elevated local strain energy. At week 42, it predicted a bone-volume fraction of 49.0% plus or minus 6.2% in the defect centre, compared with 58.4% plus or minus 8.1% in vivo. The aged loading dataset therefore showed significant deviation between simulation and observation. The model also generated a transient bone-volume peak that was absent from the experimental data. By contrast, the rejuvenated-callus scenario predicted 56.2% plus or minus 8.3% in the defect centre, close to the measured value, and its longitudinal bone-volume curves did not differ detectably from the experimental curves.

Cell-level outputs offered a mechanistic explanation for this difference. In the degenerated scenario, osteocytes exposed to substantial mechanical stimulation continued to produce elevated levels of sclerostin, suppressing osteoblast recruitment even where strain exceeded the threshold for osteogenic differentiation. The model’s qualitative outputs suggest that sclerostin dysregulation was the more proximal driver, although the study did not separately test the effects of sclerostin production and the elevated mechanosensitivity threshold. In the rejuvenated scenario, cyclic loading lowered sclerostin within the lateral callus and created a permissive environment for osteoblasts. Bone formed only where strain was sufficient, reproducing the location and scale of the experimental anabolic response while leaving the adjacent aged cortex comparatively unresponsive.

The findings support an “osteochronology” interpretation of skeletal ageing: the functional age of newly generated tissue may differ from that of the organism that produced it. The aged callus in this model behaved like a locally young unit embedded within an aged skeleton, able to detect and translate mechanical signals even though the surrounding cortex retained a quiescent state. The authors describe this as in silico evidence that the regenerative potential of a fracture callus is modulated by the functional capacity of its embedded osteocytes rather than being determined solely by the systemic environment. However, the model cannot establish that the same tissue-age separation occurs naturally in all older animals or in human fracture healing.

Several limitations constrain the conclusion. PolgA mice exhibit accelerated ageing driven by mitochondrial dysfunction and may not reproduce the full range of skeletal changes associated with natural ageing. The model treats osteocyte function as a binary choice between rejuvenated and degenerated states, although real cell populations are likely to occupy a continuum. Revascularisation was omitted because all included defects had bridged before the simulated period, leaving reduced perfusion as an untested alternative explanation for reduced native-cortex responsiveness. The mechanical conditions calibrated in young animals were assumed to apply to aged animals, although differences in body weight, activity and load partitioning could alter the true stimulus. Statistical comparisons were also underpowered, with four simulated animals per aged group, and a non-significant difference should not be interpreted as proof of equivalence.

The computational setup adds further caveats. Tissue stiffness was derived from mineral density through a linear relationship, so regions with equal density received identical elastic properties despite possible differences in collagen organisation. Osteoclast activity and the remodelling surface were simplified, producing visual discrepancies from the experimental micro-CT structures even when total bone-volume fraction was predicted accurately. The model also represented a single calibrated mechanical boundary condition for each cohort, rather than fitting the effective axial-to-bending ratio of each animal. Within those constraints, the study provides a testable explanation for a striking observation: a smaller aged callus and higher local strains were not sufficient to produce the load-driven formation observed in vivo when osteocytes were modelled as degenerated, whereas assigning the callus a youthful functional phenotype substantially improved agreement with the aged biological data.

Subject of Research: Modelling how osteocyte functional age regulates mechanical remodelling in aged mouse femur defects

Article Title: Agent-based modelling of late-stage mechanical loading of femur defects in prematurely ageing PolgA mice

Article References: Kendall, J. J., Ledoux, C., Marques, F. C., Kuhn, G. A., Schulte, F. A., & Müller, R. (2026). Agent-based modelling of late-stage mechanical loading of femur defects in prematurely ageing PolgA mice. Frontiers in Bioengineering and Biotechnology, 14, Article 1879777. https://doi.org/10.3389/fbioe.2026.1879777

Image Credits: AI Generated

DOI: 10.3389/fbioe.2026.1879777

Keywords: bone regeneration, osteocytes, agent-based modelling, mechanical loading, fracture healing, callus remodelling, cellular ageing, micro-CT, sclerostin, PolgA mice, Agent-based, modelling

A new study published in Archives of Osteoporosis now offers the most detailed portrait yet of what happens to bone in the immediate aftermath of a cerebral ischemic event. In the baseline analysis of the Post-stroke Osteopathy study, a team led by researchers at the Medical University of Innsbruck in Austria combined high-resolution peripheral quantitative computed tomography, or HR-pQCT, with an extensive panel of biochemical bone markers in a cohort of acute stroke and TIA patients. According to the investigators, this is the largest cohort of ischemic stroke or TIA patients ever examined prospectively with HR-pQCT and the first study anywhere to correlate bone biomarkers with high-resolution imaging parameters in this clinical setting.

The imaging technique at the heart of the study represents a major leap beyond conventional bone assessment. Dual-energy X-ray absorptiometry, the workhorse of osteoporosis screening, measures bone mass in two dimensions and misses critical information about bone quality. HR-pQCT, by contrast, resolves the three-dimensional microarchitecture of cortical and trabecular bone at peripheral sites such as the distal radius and distal tibia with an impressive 61-micrometer voxel size and very low radiation exposure. This matters because bone strength depends not merely on how much mineral bone contains but on its morphology and microstructure, a fact convincingly established by large international consortia showing that cortical and trabecular microarchitecture independently predict fracture risk in older women and men.

In the study, 122 participants were enrolled between March 2021 and May 2022 at the University Hospital Innsbruck as a pilot sub-study of the ongoing STROKE-CARD Registry. Of these, 116 underwent baseline HR-pQCT imaging of all four extremities within days of their event, with a median age of 71.5 years and 26.7 percent women. Neurological deficits were predominantly mild, reflected by a median National Institutes of Health Stroke Scale score of 2, and scans were performed on average 5.4 days after admission. Blood samples for biomarker analysis were drawn in 62 patients a mean of 3.0 days after admission and analyzed using validated enzyme-linked immunosorbent assays for osteocalcin, C-telopeptide of crosslinked collagen type 1, sclerostin, osteoprotegerin, soluble RANKL, and periostin.

The imaging results revealed clear patterns. Women in the cohort had lower total, cortical, and trabecular volumetric bone mineral density, along with lower values for nearly every other HR-pQCT parameter, in both the upper and lower extremities. This finding mirrors what has been documented in healthy reference populations, suggesting that stroke patients retain normal sex-based differences in bone structure. Increasing age was associated with lower total and cortical volumetric bone mineral density, but intriguingly, trabecular parameters showed no relationship with age in this cohort, a dissociation the authors suggest may be linked to higher sclerostin levels in elderly patients, which correlated with stable trabecular architecture.

Lifestyle and metabolic factors left their own signatures on the skeleton. Active or former smokers had lower total and trabecular volumetric bone mineral density in the tibia but not in the radius, consistent with prior evidence that smoking exerts a particularly strong influence on the trabecular compartment. Higher body mass index was associated with greater cortical and trabecular bone areas and higher trabecular density, especially in the radius. The weaker BMI effect in the tibia, a weight-bearing bone where mechanical loading might be expected to matter most, prompted the authors to argue that BMI captures complex systemic processes rather than simple mechanical loading, with detrimental lipotoxic and metabolic pathways potentially counteracting the localized benefits of extra weight at the lower limb.

The biomarker correlations provided some of the most novel insights of the analysis. Sclerostin, a protein secreted by osteocytes that suppresses bone formation, showed a positive correlation with trabecular HR-pQCT parameters, including trabecular volumetric bone mineral density in both the radius and the tibia, an association never before examined in a stroke or TIA population. Higher osteoprotegerin levels were linked to lower cortical area and thickness, echoing findings from the STRAMBO study of men, which similarly showed that elevated osteoprotegerin selectively affects the cortical rather than the trabecular compartment. Osteocalcin, a marker of bone turnover, correlated negatively with total volumetric bone mineral density and cortical thickness in the radius, in line with prior studies linking higher osteocalcin to increased bone turnover and skeletal fragility.

Notably, several traditional cardiovascular risk factors failed to leave any measurable trace on the skeleton in this cohort. No correlation was found between any HR-pQCT parameter and diabetes mellitus, blood pressure, or dyslipidemia, and neither stroke severity at admission nor stroke etiology, classified according to the TOAST criteria, was associated with imaging or biomarker outcomes. When the 17 patients with TIA were excluded to focus on confirmed strokes, the findings remained unchanged, reinforcing the robustness of the observed patterns. Overall, the biochemical markers exerted more influence on bone parameters in the radius than in the tibia, an asymmetry that future longitudinal follow-up may help explain.

The authors are candid about the limitations of their work. The cohort was recruited at a single center, all participants were of European descent, women were underrepresented owing to eligibility criteria such as the exclusion of patients with known osteoporosis, and HR-pQCT measurements were confined to peripheral skeletal sites that may not fully reflect changes in the axial skeleton. The acute phase after stroke may itself perturb biomarker levels, baseline blood sampling was not feasible in all patients, and the exploratory correlation analyses, involving many comparisons without formal adjustment for multiple testing, warrant cautious interpretation. The absence of an in-house, age-matched healthy control group further means the baseline findings describe the absolute bone status of acute patients rather than stroke-specific deviations.

Even so, the study establishes a crucial foundation. By pairing the finest available in vivo images of bone microstructure with a comprehensive biochemical profile gathered within days of a cerebral ischemic event, the Innsbruck team has created the reference point against which future bone loss after stroke can be measured. The prospective design of the Post-stroke Osteopathy study, with follow-up imaging and blood sampling at 3, 6, and 12 months, promises to chart the trajectory of skeletal deterioration and to clarify whether the biomarker signals identified at baseline predict which patients will go on to suffer the devastating fractures that raise mortality and erode quality of life after stroke. If those predictions hold, routine bone microarchitecture screening and early targeted intervention could become standard components of post-stroke care.

Subject of Research: Bone microarchitecture and biomarker characteristics in patients after ischemic stroke or transient ischemic attack assessed with HR-pQCT imaging

Article Title: High-resolution peripheral quantitative computed tomography imaging and bone biomarker characteristics of patients with ischemic stroke or transient ischemic attack—baseline analysis of the Post-stroke Osteopathy study

Article References: Dejakum, B., Bereiter-Payr, J., Felicetti, S., Moelgg, K., Karisik, A., Degenhart, G., Toell, T., Boehme, C., Mayer-Suess, L., Pechlaner, R., Liphardt, A.-M., Berg, G., Schett, G., Kiechl, S., & Knoflach, M. (2026). High-resolution peripheral quantitative computed tomography imaging and bone biomarker characteristics of patients with ischemic stroke or transient ischemic attack—baseline analysis of the Post-stroke Osteopathy study. Archives of Osteoporosis, 21(1), Article 134. https://doi.org/10.1007/s11657-026-01767-w

Image Credits: AI Generated

DOI: 10.1007/s11657-026-01767-w

Keywords: ischemic stroke, transient ischemic attack, HR-pQCT, bone microarchitecture, post-stroke osteopathy, bone biomarkers, osteoporosis, fracture risk, sclerostin, osteoprotegerin, osteocalcin, volumetric bone mineral density